Smithtown, NY, United States of America

Nungavarum S Ramamurthy

This inventor holds 1 USPTO granted patent. Top assignee: The State University of New York. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nungavarum S Ramamurthy. Retrieved from https://idiyas.com/inventor/nungavarum-s-ramamurthy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 68(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nungavarum S Ramamurthy: Innovator in Medical Treatments

Introduction

Nungavarum S Ramamurthy is a notable inventor based in Smithtown, NY (US). He has made significant contributions to the field of medicine, particularly in the treatment of conditions associated with excessive extracellular protein glycosylation.

Latest Patents

Ramamurthy holds a patent for a method involving tetracyclines, specifically targeting non-antimicrobial chemically-modified tetracyclines. This innovative approach aims to treat mammals suffering from conditions such as diabetes, scleroderma, and progeria by administering a tetracycline that effectively inhibits excessive protein glycosylation.

Career Highlights

He is affiliated with the State University of New York, where he continues to advance his research and contribute to the scientific community. His work has garnered attention for its potential impact on treating serious health conditions.

Collaborations

Some of his notable coworkers include Lorne M Golub and Thomas F McNamara, who have collaborated with him on various research projects.

Conclusion

Nungavarum S Ramamurthy's innovative work in the medical field highlights the importance of research in developing effective treatments for complex health issues. His contributions continue to pave the way for advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…